Patents by Inventor Gerd Maass

Gerd Maass has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • System for the production of AAV vectors
    Patent number: 6541012
    Abstract: The invention concerns a system comprising an AAV vector, which contains a foreign DNA, and rep 68/78 sequences of AAV with delayed expression, these sequences being present (a) in cis or (b) in trans. The invention also concerns the use of such a system for the production of AAV vectors.
    Type: Grant
    Filed: July 18, 2001
    Date of Patent: April 1, 2003
    Inventors: Christoph Bogedain, Gerd Maass, Michael Hallek
  • Recombinant AAV vector-based transduction system and use of same
    Publication number: 20020192826
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.
    Type: Application
    Filed: August 12, 2002
    Publication date: December 19, 2002
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • Recombinant AAV vector-based transduction system and use of same
    Patent number: 6440742
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.
    Type: Grant
    Filed: January 30, 2001
    Date of Patent: August 27, 2002
    Assignee: Medigene, AG
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • System for the production of AAV vectors
    Publication number: 20020081709
    Abstract: The invention concern a system comprising an AAV vector, which contains a foreign DNA, and rep 68/78 sequences of AAV with delayed expression, these sequences being present (a) in cis or (b) in trans.
    Type: Application
    Filed: July 18, 2001
    Publication date: June 27, 2002
    Applicant: MEDIGENE AG.
    Inventors: Christoph Bogedain, Gerd Maass, Michael Hallek
  • Recombinant AAV vector-based transduction system and use of same
    Publication number: 20020028514
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. Furthermore, this invention concerns the use of the transduction system.
    Type: Application
    Filed: January 31, 2001
    Publication date: March 7, 2002
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl
  • System for the production of AAV vectors
    Patent number: 6294370
    Abstract: The invention concerns a system comprising an AAV vector, which contains a foreign DNA, and rep 68/78 sequences of AAV with delayed expression, these sequences being present (a) in cis or (b) in trans. The invention also concerns the use of such a system for the production of AAV vectors.
    Type: Grant
    Filed: August 6, 1999
    Date of Patent: September 25, 2001
    Assignee: Medigene AG
    Inventors: Christoph Bogedain, Gerd Maass, Michael Hallek
  • Recombinant AAV vector-based transduction system and use of same
    Patent number: 6207453
    Abstract: The present invention relates to a transduction system, comprising (a) a rep-negative AAV vector containing a foreign DNA and (b) a product providing an AAV Rep protein. The invention also relates to the use of the transduction system.
    Type: Grant
    Filed: May 5, 1999
    Date of Patent: March 27, 2001
    Assignee: Medigene AG
    Inventors: Gerd Maass, Christoph Bogedain, Michael Hallek, Clemens Wendtner, Doris Michl